SENO Senorx (MM)

Levi & Korsinsky is investigating the Board of Directors of SenoRx, Inc. (“SenoRx” or the “Company”) (NasdaqGM: SENO) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to C.R. Bard Inc. ("C.R. Bard") (NYSE: BCR). Under the terms of the transaction, SenoRx shareholders will receive $11.00 in cash for each SenoRx share of common stock they own for a total transaction value of approximately $213 million.

The investigation concerns whether the SenoRx Board of Directors breached their fiduciary duties to SenoRx stockholders by failing to adequately shop the Company before entering into this transaction and whether C.R. Bard is underpaying for SenoRx shares, thus unlawfully harming SenoRx stockholders. In particular, the offer price is only a small premium over the $10.17 price the Company's shares traded at as recently as April 27, 2010 and the SenoRx Board of Directors agreed to a strict "no solicitation" provision and agreed to pay a $9.0 million termination fee under certain circumstances.

If you own common stock in SenoRx and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500 or visit http://www.zlk.com/senorx.html.

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation.

Senorx (MM) (NASDAQ:SENO)
Historical Stock Chart
From Oct 2024 to Nov 2024

Senorx (MM) (NASDAQ:SENO)
Historical Stock Chart
From Nov 2023 to Nov 2024